-
Mashup Score: 73
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 73
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S. https://t.co/mrWWLIqU47
-
-
Mashup Score: 73
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S. https://t.co/mrWWLIqU47
-
-
Mashup Score: 73
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S. https://t.co/mrWWLIqU47
-
-
Mashup Score: 2
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way investors view emerging candidates.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
RT @adamfeuerstein: What Novo Nordisk’s $NVO disappointing trial results mean for the obesity drug market https://t.co/MpAQ5DsVmL via @elai…
-
-
Mashup Score: 50
Ionis won FDA approval for a drug for patients with a deadly genetic disease that impedes the body’s ability to break down fats
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Ionis Pharmaceuticals rare disease drug wins FDA approval https://t.co/SSaMsL4qBs
-
-
Mashup Score: 8
Novo Nordisk’s next-gen obesity drug led patients to lose substantial weight, but fell short of expectations.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Novo Nordisk's next-gen obesity drug underperforms in trial, @elaineywchen writes. https://t.co/7lV9Hrz5CB
-
-
Mashup Score: 15
The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed stimulation via electrodes placed on back of neck.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
FDA OKs novel device for non-invasive treatment of spinal cord injuries Onward Medical’s ARC-EX may offer ‘a whole new paradigm’ https://t.co/PQCVb5dHca
-
-
Mashup Score: 50
Ionis won FDA approval for a drug for patients with a deadly genetic disease that impedes the body’s ability to break down fats
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Ionis Pharmaceuticals rare disease drug wins FDA approval https://t.co/SSaMsL4qBs
-
-
Mashup Score: 4
Lawmakers are aiming to pass a government funding bill with extensions for public health programs and telehealth flexibilities.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
House GOP drops PBM reform from government funding bill https://t.co/mj6ueNQSoq
-
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S. https://t.co/mrWWLIqU47